VTYX
Ventyx Biosciences Inc
Clinical-stage biopharmaceutical company developing oral therapies for autoimmune, inflammatory and neurodegenerative diseases
CUSIP: 92332V107HealthcareUS1 holder
Total Value
$32.79M
Total Shares
1.00M
Net Share Change
-3.31M
Activity
1 selling
Investor
Value
Shares
Weight
Change
Third Point LLC
$32.79M1.00M shares
TRIM-3.31M(-76.8%)